Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma

Active, not recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

July 8, 2020

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions

Brain NeoplasmLow Grade GliomaSeizure Disorder

Interventions

OTHER

Survey Administration

Complete survey

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER